ஜர்னல் ஆஃப் லிவர்: நோய் மற்றும் மாற்று அறுவை சிகிச்சை

Nonalcoholic Fatty Liver Disease (NAFLD) after Liver Transplantation: A Mini-Review

Claudia P Oliveira, Mario R Alvares-da-Silva and Luiz A Carneiro Dalbuquerque

Nonalcoholic Fatty Liver Disease (NAFLD) after Liver Transplantation: A Mini-Review

Nonalcoholic fatty liver disease (NAFLD) encompasses a large spectrum of disease including simple steatosis, nonalcoholic steatohepatitis (NASH) and in some patients liver fibrosis, cirrhosis, liver failure and hepatocellular carcinoma. In the last few years NAFLD has became the most common liver disease in Western countries and has been recognized an important indication for the liver transplantation as well. Advances in medical therapy and surgical techniques have transformed the long-term survival of liver-transplant (LT) recipients. Currently metabolic syndrome and NAFLD recurrence or de novo NAFLD are common among LT NAFLD recipients since they present an increased risk of metabolic disturbances as a natural result of their personal characteristics.